A decade of immune-checkpoint inhibitors in cancer therapy
A decade of immune-checkpoint inhibitors in cancer therapy
复制标题
DOI:
10.1038/s41467-020-17670-y
复制
发表时间:
2020-07-30
影响因子:
16.6
通讯作者:
Robert, Caroline
中科院分区:
文献类型:
--
作者:
Robert, Caroline
Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.